Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226
Heba F. Ashour, Laila Abou‐Zeid, Magda A.‐A. El‐Sayed, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112062-112062
Closed Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Anticancer perspectives of monocarbonyl analogs of curcumin: A decade (2014–2024) review
Amol A. Nagargoje, Tejshri R. Deshmukh, Mubarak H. Shaikh, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 9
Closed Access | Times Cited: 3
Synthesis and biological evaluation of halogenated phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast cancer
Peter A. Halim, Rasha A. Hassan, Khaled O. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 37, Iss. 1, pp. 189-201
Open Access | Times Cited: 20
Synthesis, α-Glucosidase Inhibitory Activity and Molecular Docking Study of Chalcone Derivatives Bearing a 1<i>H</i>-1,2,3-Triazole Unit
Bayu Ardiansah, Nur Rohman, Mochammad Arfin Fardiansyah Nasution, et al.
Chemical and Pharmaceutical Bulletin (2023) Vol. 71, Iss. 5, pp. 342-348
Open Access | Times Cited: 8
Design, synthesis, and antioxidant evaluation of monocarbonyl curcumin analogues tethered 1,2,3-triazole scaffold
Bayu Ardiansah, Muhammad Ridho Hardhani, Decky Duem Syaban Ridho Putera, et al.
Case Studies in Chemical and Environmental Engineering (2023) Vol. 8, pp. 100425-100425
Open Access | Times Cited: 8
Synthesis, characterization, cytotoxic evaluation, and molecular docking studies of novel 1,2,3-triazole-based chalcones for potential anticancer applications
Venkateswarlu Banoji, A. Kishore Kumar, V. Sunitha, et al.
Results in Chemistry (2023) Vol. 7, pp. 101294-101294
Open Access | Times Cited: 8
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
2H-1,2,3-Triazole-chalcones as novel cytotoxic agents against prostate cancer
Sérgio Pinheiro, J. C. Pessôa, Erick M.C. Pinheiro, et al.
Bioorganic & Medicinal Chemistry Letters (2020) Vol. 30, Iss. 19, pp. 127454-127454
Closed Access | Times Cited: 16
A Photoinduced Multicomponent Regioselective Synthesis of 1,4,5‐Trisubstituted‐1,2,3‐Triazoles: Transition Metal‐, Azide‐ and Oxidant‐Free Protocol
Bhargava Sai Allaka, Srinivas Basavoju, Gamidi Rama Krishna
Advanced Synthesis & Catalysis (2021) Vol. 363, Iss. 14, pp. 3560-3565
Closed Access | Times Cited: 14
Facile synthesis, antimicrobial screening and docking studies of pyrrole-triazole hybrids as potential antimicrobial agents
Monika Yadav, Aman Kumar, Kashmiri Lal, et al.
Research on Chemical Intermediates (2023) Vol. 49, Iss. 4, pp. 1311-1326
Closed Access | Times Cited: 5
Synthesis and characterization of some benzidine-based azomethine derivatives with molecular docking studies and anticancer activities
Musa Erdoğan, Ali Yeşildağ, Barış Yıldız, et al.
Chemical Papers (2023) Vol. 77, Iss. 11, pp. 6829-6847
Closed Access | Times Cited: 5
Design, synthesis, and evaluation of new benzimidazole‏ ‏‎thiourea ‎derivatives as antitumor agents
Mohamed Abou-Taleb, Nadia S. El‐Gohary, Hazem A. Ghabbour, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 5
Antiproliferative effect of mitochondria-targeting allobetulin 1,2,3-triazolium salt derivatives and their mechanism of inducing apoptosis of cancer cells
Rui Wang, Yang Li, Wim Dehaen
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112737-112737
Closed Access | Times Cited: 14
Design, Synthesis and In Silico Molecular Docking Evaluation of New Series of 1,2,3‐Triazole Derivatives as Potent Antimicrobial Agents
Venkatesan Vellaiyan, H. Nagarajaiah, Adamshafi Shaik, et al.
ChemistrySelect (2024) Vol. 9, Iss. 15
Closed Access | Times Cited: 1
Semisynthesis of novel chalcone hybrid compounds linked by 1,2,3-triazole and evaluation of their cytotoxic effects
Yassine Laamari, Mourad Fawzi, Ali Oubella, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139648-139648
Closed Access | Times Cited: 1
Antibacterial and antitumoral properties of 1,2,3-triazolo fused triterpenes and their mechanism of inhibiting the proliferation of HL-60 cells
Rui Wang, Yang Li, Haibo Hu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113727-113727
Closed Access | Times Cited: 12
Thiazole ring-cleavage: Versatile products obtained in the course of synthesis of certain sulfonamide derivatives
Mohamed A. Zeidan, Dina I. A. Othman, Fatma E. Goda, et al.
Journal of Molecular Structure (2023) Vol. 1279, pp. 135018-135018
Closed Access | Times Cited: 4
Design, synthesis, and unraveling the antibacterial and antibiofilm potential of 2-azidobenzothiazoles: insights from a comprehensive in vitro study
Tanzeela Qadir, Saadat A. Kanth, Mohammad Aasif, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 4
Therapeutic potential of 1,2,3‐triazole hybrids for leukemia treatment
Wenchao Yang, Bixia Xuan, Xiaofang Li, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 7
New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies
Samira Nashaat, Morkos A. Henen, Shahenda M. El‐Messery, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5245-5245
Open Access | Times Cited: 7
Discovery of novel 1,2,4-triazine-chalcone hybrids as anti-gastric cancer agents via an axis of ROS-ERK-DR5 in vitro and in vivo
Liu Chong, Jian Song, Xinxin Cui, et al.
Arabian Journal of Chemistry (2021) Vol. 15, Iss. 3, pp. 103644-103644
Open Access | Times Cited: 10
New 3‐(1H‐benzo[d]imidazol‐2‐yl)quinolin‐2(1H)‐one‐based triazole derivatives: Design, synthesis, and biological evaluation as antiproliferative and apoptosis‐inducing agents
Nikhil Baliram Gaikwad, Sapana Bansod, S.S. Biradar, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 11
Closed Access | Times Cited: 9
Exploration of 1,2,3‐triazolo fused triterpenoids as inhibitors of human coronavirus 229E targeting the viral nsp15 protein
Rui Wang, Annelies Stevaert, Tien T. Nguyen, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 1
Open Access | Times Cited: 3
Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction
Mohamed A. Zeidan, Dina I. A. Othman, Fatma E. Goda, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 2
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway
Qing Su, Baolin Xu, Zhoubin Tian, et al.
Acta Pharmaceutica (2022) Vol. 72, Iss. 3, pp. 389-402
Open Access | Times Cited: 4
An Efficient Access to 5‐(1,2,3‐Triazol‐1‐yl)isoxazoles – Previously Unknown Structural Type of Triazole‐isoxazole Hybrid Molecule
Dmitry A. Vasilenko, Sevastian E. Dronov, Yuri K. Grishin, et al.
Asian Journal of Organic Chemistry (2022) Vol. 11, Iss. 9
Closed Access | Times Cited: 4

Scroll to top